Roche revises Tamiflu precautions

Share this article:
Roche has revised the precautions on Tamiflu based on reports from Japan about “self-injury and delirium,” according to an FDA MedWatch notice. “People with the flu, particularly children, may be at an increased risk of self-injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior,” the FDA says.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions